PDF
File
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Calmark Sweden AB (publ) announces today that the registration of the subsidiary in mainland China has been approved by local authorities. The name of the new company is 凯曼克医疗器械（无锡）有限公司 (Calmark Med-tech (Wuxi) Limited company).
As previously disclosed, the new subsidiary will be located in Wuxi, a growth area just outside Shanghai. The corporate office will be located at I·Campus, Astra Zeneca's life science startup hub; this opens opportunities for cooperation with other, similar companies and local organizations with experience of registration of foreign products in China.
Together with the consultancy firm Nordic Match, Calmark has now also prepared an information memorandum (IM) for the planned joint venture. Discussions with interested Chinese investors are underway.
"We are exceedingly happy about the constructive cooperation with Nordic Match", says Anna Söderlund, CEO of Calmark. "Their solid experience of cross-border transactions between China and the Nordic countries, entrepreneurial mindset and great passion for business are most valuable to us at this stage."